Purissima Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
25
- Latest Deal Type
-
2ndary - Private
- Investors
-
10
Purissima General Information
Description
Operator of a wellness ingredient company intended to promote health and well-being among customers. The company's platform offers a wide range of therapeutics, dietary supplements, and wellness ingredients, using fermentation, for personal care, consumer health, and nutrition at an affordable rate, enabling therapeutic firms to produce pure, natural ingredients at a commercial scale for global wellness brands.
Contact Information
Website
www.purissima.bioCorporate Office
- 329 Oyster Point Boulevard
- Suite 300
- South San Francisco, CA 94080
- United States
Corporate Office
- 329 Oyster Point Boulevard
- Suite 300
- South San Francisco, CA 94080
- United States
Purissima Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Secondary Transaction - Private | Completed | Generating Revenue | ||||
| 4. Early Stage VC (Series B) | 31-Dec-2020 | Completed | Generating Revenue | |||
| 3. Early Stage VC (Series A) | 01-Mar-2019 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 06-Jul-2017 | Completed | Startup | |||
| 1. Seed Round | 01-Jan-2017 | Completed | Startup |
Purissima Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Purissima Patents
Purissima Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2023064731-A1 | Neurotransmitters and methods of making the same | Inactive | 15-Oct-2021 | ||
| CA-3059797-A1 | Neurotransmitters and methods of making the same | Pending | 05-May-2017 | ||
| EP-3619301-A1 | Neurotransmitters and methods of making the same | Inactive | 05-May-2017 | ||
| EP-3619301-A4 | Neurotransmitters and methods of making the same | Inactive | 05-May-2017 | ||
| US-10704066-B2 | Neurotransmitters and methods of making the same | Inactive | 05-May-2017 | C12P17/06 |
Purissima Signals
Purissima Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| AgFunder | Venture Capital | Minority | ||
| Band of Angels | Angel Group | Minority | ||
| Cantina Angels | Angel Group | Minority | ||
| Angel (individual) | Minority | |||
| Life Science Angels | Angel Group | Minority |
Purissima FAQs
-
When was Purissima founded?
Purissima was founded in 2017.
-
Where is Purissima headquartered?
Purissima is headquartered in South San Francisco, CA.
-
What is the size of Purissima?
Purissima has 25 total employees.
-
What industry is Purissima in?
Purissima’s primary industry is Drug Discovery.
-
Is Purissima a private or public company?
Purissima is a Private company.
-
What is Purissima’s current revenue?
The current revenue for Purissima is .
-
How much funding has Purissima raised over time?
Purissima has raised $5.1M.
-
Who are Purissima’s investors?
AgFunder, Band of Angels, Cantina Angels, , and Life Science Angels are 5 of 10 investors who have invested in Purissima.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process